Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
REDEEM, 2009 | dabigatran | placebo | | | Negative | NCT00621855 |
|
RE-LY 150mg (2nd prevention subgroup) | dabigatran 150mg | warfarin | | Exploratory | Suggesting | |
phase 2 dabigatran | dabigatran | warfarin standard dose | | Exploratory | - | NCT01136408 |
PETRO (150mg), 2007 | dabigatran 150mg | warfarin standard dose | | Exploratory | - | |
RE-LY (150mg), 2009 | dabigatran 150mg | warfarin standard dose | | Risk of bias | Suggesting | NCT00262600 |
RE-LY (110mg), 2009 | dabigatran 110mg | warfarin standard dose | | Risk of bias | Suggesting | NCT00262600 |
RE-LY 110mg (2nd prevention subgroup) , 2010 | dabigatran 100mg | warfarin | | Exploratory | Suggesting | |
|
REDEEM, 2009 | dabigatran | placebo | | | Negative | NCT00621855 |
|
REDEEM, 2009 | dabigatran | placebo | | | Negative | NCT00621855 |
|
RE-NOVATE 2 | dabigatran 220mg | enoxaparin | hip surgery | Low risk of bias | Negative | NCT00657150 |
RE-NOVATE (220mg), 2007 | dabigatran 220mg | enoxaparin | hip surgery | Low risk of bias | Negative | NCT00168818 |
RE-NOVATE (150mg), 2007 | dabigatran 150mg | enoxaparin | hip surgery | Low risk of bias | Negative | NCT00168818 |
RE-MODEL (220mg), 2007 | dabigatran 220mg | enoxaparin (europe regimen) | knee surgery | Low risk of bias | Negative | |
RE-MODEL (150mg), 2007 | dabigatran 150mg | enoxaparin (europe regimen) | knee surgery | Low risk of bias | Negative | |
RE-MOBILIZE (220mg), 2008 | dabigatran 220mg | enoxaparin (US regimen) | knee surgery | Low risk of bias | Negative | |
RE-MOBILIZE (150mg), 2008 | dabigatran 150mg | enoxaparin (US regimen) | knee surgery | Low risk of bias | Negative | |
|
RE-COVER, 2009 | heparin/dabigatran | heparin/VKA | | Low risk of bias | Suggesting | NCT00291330 |
RE-SONATE, 2011 | dabigatran | discontinuation | | | Suggesting | NCT00558259 |
RE-COVER II, 2011 | heparin/dabigatran | heparin/VKA | | | Suggesting | NCT00680186 |
RE-MEDY, 2011 | dabigatran | warfarin | | Low risk of bias | Suggesting | NCT00329238 |